Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of the American College of Cardiology (JACC)
In patients with both cirrhosis and atrial fibrillation, apixaban initiation was associated with lower rates of major bleeding compared to rivaroxaban or warfarin, without compromising thromboembolic protection.
Cardiology August 5th 2024
The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.
The New England Journal of Medicine
Purulent pericarditis, while rare, remains a potentially fatal complication that requires prompt recognition and management, particularly in patients with a history of intravenous drug use.
Elevated plasma Lp(a) concentrations were associated with a 41% faster progression of peak aortic jet velocity and a 57% faster progression of mean transvalvular gradient in patients with aortic stenosis.
Rapid optimization of guideline-directed medical therapy in heart failure patients post-discharge was associated with sustained decongestion and improved clinical outcomes at 90 days.
The study found that while PASC risk has decreased over time, it remains a significant concern even among vaccinated individuals infected during the omicron era.
Allergy & Immunology July 31st 2024